What is the insulin sensitivity factor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is the Insulin Sensitivity Factor?

The insulin sensitivity factor (ISF), also called the correction factor, is an individualized measure of how much 1 unit of insulin will decrease blood glucose—for example, with a ratio of 1:3, one unit of insulin would decrease blood glucose by 3 mmol/L (or approximately 54 mg/dL). 1

Clinical Purpose and Application

The ISF serves a specific therapeutic function distinct from meal-time insulin dosing:

  • It is used to calculate correction boluses that bring elevated blood glucose back to a predetermined target level before meals, independent of carbohydrate intake 1
  • The correction dose is calculated by dividing the difference between current blood glucose and target blood glucose by the ISF 2
  • For example, if blood glucose is 250 mg/dL, target is 100 mg/dL, and ISF is 50 mg/dL per unit, the correction dose would be (250-100)/50 = 3 units 2

Calculation and Individualization

The ISF is calculated from the patient's total daily dose of insulin and reflects their overall insulin sensitivity, similar to the insulin-to-carbohydrate ratio 1

Key characteristics of ISF determination:

  • It is preprogrammed into insulin pumps and used by the on-board calculator to automatically compute correction doses when the user inputs their current blood glucose 1
  • The ISF value varies between individuals based on body weight, insulin resistance, and metabolic factors 2
  • ISF is not fixed—it requires periodic reassessment as insulin requirements change with weight, exercise patterns, menstrual cycles, and other physiological changes 2

Integration with Insulin Delivery Systems

Modern insulin delivery incorporates ISF in sophisticated ways:

  • Insulin pumps contain preset memory that calculates "insulin on board" from previous doses, preventing excessive correction doses ("stacking") that could cause hypoglycemia 1
  • Advanced hybrid closed-loop systems may use machine learning to optimize correction factors on an ongoing basis 1
  • Some newer automated insulin delivery (AID) systems provide automated correction boluses at varying frequencies, with the dose and timing determined by the programmed ISF 1

Common Clinical Pitfalls

Failing to account for insulin on board from previous boluses can lead to insulin stacking and dangerous hypoglycemia 2

Additional considerations to avoid errors:

  • Hyperglycemia itself induces short-term insulin resistance, meaning the ISF may be less effective at very high glucose levels, requiring larger correction doses than the standard ISF would predict 3
  • ISF typically varies throughout the day due to diurnal hormonal changes, though most systems use a single value or limited time blocks 1
  • Changes in activity level, illness, or medications (especially corticosteroids) can temporarily alter insulin sensitivity, making the programmed ISF inaccurate 1

Relationship to Other Insulin Parameters

The ISF works in conjunction with other insulin dosing parameters:

  • The total mealtime bolus combines both the meal bolus (based on carbohydrate-to-insulin ratio) and the correction bolus (based on ISF) 2
  • Unlike the carbohydrate-to-insulin ratio which addresses food intake, the ISF specifically addresses hyperglycemia correction 1
  • Both parameters should be reviewed every 3-6 months in pump therapy clinics and adjusted based on glucose patterns 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Calculating Insulin to Carb Ratio and Correction Factor for Optimal Blood Glucose Control

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Modeling the variability of insulin sensitivity for people with Type 1 Diabetes based on clinical data from an artificial pancreas study.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.